Delivery Order SPE2DB24D2205-SPE2DB25FEHDP
- Not listed
- The Defense Logistics Agency awarded a $2,521.96 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Eohilia 2 mg/10 ml stick pack pharmaceuticals. The contract represents a firm fixed price delivery order with a completion date of September 17, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- On August 29, 2025, the Defense Logistics Agency awarded a delivery order valued at $9,102.69 to AmerisourceBergen Drug Corp for the supply of Eohilia 2 mg/10 ml stick pack pharmaceutical product. This firm fixed-price, non-set-aside contract is to be performed in Conshohocken, Pennsylvania, with an ultimate completion date of September 2, 2025. The delivery order operates under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $1,260.98 to AmerisourceBergen Drug Corp for Eohilia 2 mg/10 ml stick pack pharmaceutical supplies on August 11, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and calls for delivery to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 12, 2025. The delivery order is executed under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,260.98 to AmerisourceBergen Drug Corp for Eohilia 2 mg/10 ml stick pack pharmaceutical product, with an ultimate completion date of August 11, 2025. This competitive delivery order, utilizing firm fixed pricing, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Eohilia 2 mg/10 ml stick pack in 10 ml units with a ceiling value of $4,832.52. This is a firm fixed-price delivery order with an ultimate completion date of April 25, 2025, and no set-aside designation was applied. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,918.78 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Eohilia 2 mg/10 ml stick pack medication. The contract, which is non-set-aside and competitively awarded, has an ultimate completion date of September 8, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $13,962.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp on April 25, 2025, for the supply of Eohilia 2 mg/10 ml stick pack pharmaceutical products. This is a non-set-aside competitive award with an ultimate completion date of April 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $4,275.60 to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Eohilia 2 mg/10 ml stick pack units. The contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award. Performance is scheduled for completion by August 20, 2025, with the place of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $14,411.01 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Eohilia 2 mg/10 mL stick pack units. This firm fixed-price delivery order, with an ultimate completion date of July 31, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. No set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $12,367.10 to AmerisourceBergen Drug Corp for Eohilia 2 mg/10 ml stick pack pharmaceutical products, with a completion date of August 27, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEHDPDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Eohilia 2 mg/10 mL stick pack medication with a ceiling value of $5,043.92. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of September 8, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to supply diverse pharmaceutical products and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The DLA's Pharmaceutical Prime Vendor Global Program is planning to establish Generation V contracts with multiple regional awards, positioning AmerisourceBergen Drug Corp as a key strategic partner in supporting military healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 9/5/25 |